| Secondary | 
									
											
										
											| Drug Use For Unknown Indication | 25.4% |  
											| Hypertension | 17.9% |  
											| Drug Exposure In Utero | 14.9% |  
											| Migraine | 6.0% |  
											| Infection Parasitic | 4.5% |  
											| Pain | 4.5% |  
											| Product Used For Unknown Indication | 4.5% |  
											| Arterial Thrombosis | 3.0% |  
											| Back Pain | 3.0% |  
											| Analgesia | 1.5% |  
											| Blood Cholesterol Increased | 1.5% |  
											| Diabetes Mellitus | 1.5% |  
											| Erectile Dysfunction | 1.5% |  
											| Essential Hypertension | 1.5% |  
											| Fungal Infection | 1.5% |  
											| Hypothyroidism | 1.5% |  
											| Infection | 1.5% |  
											| Insomnia | 1.5% |  
											| Psoriatic Arthropathy | 1.5% |  
											| Shoulder Pain | 1.5% |  | 
									
											
										
											| Syncope | 22.2% |  
											| Metabolic Acidosis | 16.7% |  
											| Migraine | 11.1% |  
											| Dizziness | 5.6% |  
											| Drug Effect Decreased | 5.6% |  
											| Insomnia | 5.6% |  
											| Intentional Overdose | 5.6% |  
											| Renal Impairment | 5.6% |  
											| Sinus Tachycardia | 5.6% |  
											| Speech Disorder Developmental | 5.6% |  
											| Vasculitis | 5.6% |  
											| Weight Increased | 5.6% |  | 
							
						
							| Concomitant | 
									
											
										
											| Product Used For Unknown Indication | 21.9% |  
											| Cancer Pain | 12.1% |  
											| Prophylaxis | 9.6% |  
											| Prostate Cancer Metastatic | 6.5% |  
											| Prostate Cancer | 6.4% |  
											| Hypertension | 5.9% |  
											| Pain | 4.1% |  
											| Back Pain | 3.7% |  
											| Crohn's Disease | 3.4% |  
											| Diabetes Mellitus | 3.1% |  
											| Drug Use For Unknown Indication | 3.0% |  
											| Rheumatoid Arthritis | 2.7% |  
											| Spinal Cord Compression | 2.7% |  
											| Infection | 2.4% |  
											| Nausea | 2.4% |  
											| Vitamin Supplementation | 2.2% |  
											| Constipation | 2.1% |  
											| Prophylaxis Of Nausea And Vomiting | 2.1% |  
											| Anxiety | 1.9% |  
											| Hormone Therapy | 1.9% |  | 
									
											
										
											| Hepatic Encephalopathy | 7.8% |  
											| Vomiting | 7.8% |  
											| Sepsis | 6.3% |  
											| Terminal State | 6.3% |  
											| Therapeutic Response Decreased | 6.3% |  
											| Weight Increased | 6.3% |  
											| Incorrect Dose Administered | 4.7% |  
											| Intestinal Obstruction | 4.7% |  
											| Myalgia | 4.7% |  
											| Pneumonia | 4.7% |  
											| Post Procedural Haemorrhage | 4.7% |  
											| Pulmonary Embolism | 4.7% |  
											| Rectal Haemorrhage | 4.7% |  
											| Respiratory Tract Infection | 4.7% |  
											| Somnolence | 4.7% |  
											| Spinal Cord Compression | 4.7% |  
											| Hyperventilation | 3.1% |  
											| Melaena | 3.1% |  
											| Musculoskeletal Pain | 3.1% |  
											| Nausea | 3.1% |  | 
							
						
							| Interacting | 
									
											
										
											| Smoking Cessation Therapy | 100.0% |  |  |